REGISTERED
on 14 Nov 2023
Last Applicant/ Owned by
5980 Horton Street
Emeryville
CA
94608
Serial Number
88639742 filed on 02th Oct 2019
Registration Number
7219011 registered on 14th Nov 2023
Correspondent Address
Lisa Greenwald-Swire
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
KYVERNA
Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
Classification Information
Class [005]
Pharmaceutical Products
Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
First Use Date in General
19th Sep 2023
First Use Date in Commerce
19th Sep 2023
Mark Details
Serial Number
No 88639742
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 479020013001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 14th Nov 2023 | REGISTERED-PRINCIPAL REGISTER |
| 14th Nov 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 07th Oct 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 06th Oct 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 26th Sep 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 22nd Sep 2023 | TEAS STATEMENT OF USE RECEIVED |
| 22nd Sep 2023 | USE AMENDMENT FILED |
| 30th Mar 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Mar 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th Mar 2023 | SOU EXTENSION 5 GRANTED |